Results from five phase III studies presented for GSK’s two candidate quadrivalent influenza vaccines
22 October 2012 | By GlaxoSmithKline
Results from five Phase III studies were presented at the IVW congress...
List view / Grid view
News
Pfizer to acquire NextWave Pharmaceuticals, Inc.
22 October 2012 | By Pfizer
Pfizer has announced its intention to acquire NextWave Pharmaceuticals...
Phase IIa laquinimod trial results show positive data for potential use in active crohn’s disease
22 October 2012 | By Teva Pharmaceutical Industries Ltd
TEVA and Active Biotech announced the presentation of Phase IIa clinical data...
Sirius Analytical product launch: Novel particle size analysis and digital image analysis combined
22 October 2012 | By Sirius Analytical Instruments Ltd
Sirius Analytical Instruments Ltd announces the introduction of a new product...
Tresiba® and Ryzodeg® receive positive opinions from the European regulatory authorities
19 October 2012 | By Novo Nordisk
Tresiba® and Ryzodeg® receive positive opinions...
Abbott receives positive opinion from CHMP for HUMIRA® use in pediatric crohn’s disease
19 October 2012 | By Abbott
The CHMP has adopted a positive opinion for HUMIRA®...
Japan’s Pharmaceuticals and Medical Devices Agency publishes assessment report of Tresiba®
19 October 2012 | By Novo Nordisk
Japan’s PMDA has published an assessment report of Tresiba®...
FDA Advisory Committee recommends KYNAMRO™ for homozygous familial hypercholesterolemia
18 October 2012 | By Sanofi
"We are very encouraged by the support for KYNAMRO..."
Biogen Idec receives notification of PDUFA date extension
18 October 2012 | By Biogen Idec
Biogen Idec announced that the U.S. FDA has extended the initial PDUFA date for its review...
Pfizer announces top-line results from phase 3 trial of INLYTA® (axitinib)
17 October 2012 | By Pfizer
In treatment-naïve patients with advanced renal cell carcinoma...
VICTRELIS® (boceprevir) awarded 2012 Prix Galien USA Best Pharmaceutical Agent
17 October 2012 | By Merck
VICTRELIS® has received the Prix Galien USA Award for best pharmaceutical agent
Bristol-Myers Squibb’s YERVOY® awarded prestigious Prix Galien USA prize for best biotechnology product
17 October 2012 | By Bristol-Myers Squibb Company
Yervoy also shortlisted for Prix Galien Prize in Germany...
Biogen Idec receives notification of PDUFA date extension
17 October 2012 | By Biogen Idec
Biogen Idec announced that the U.S. FDA has extended the initial PDUFA date...
Further success for CI Precision’s dispensary management software in India
16 October 2012 | By CI Precision
CI Precision has been awarded a new contract...
Increased flexibility and choice for Tecan’s Cavro® Centris Pump
16 October 2012 | By kdm communications limited
The state-of-the-art Cavro Centris Pump from Tecan is now available...
